Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nippon Chemiphar completes phase I trial of NC-2500 and preclinical studies with NC-2700

Nov. 30, 2017

Kyowa Hakko Kirin licenses tenapanor rights in Japan from Ardelyx

Nov. 28, 2017

MA-0217 as a promising new agent for ischemic acute kidney injury

Nov. 27, 2017

New vasopressin receptor antagonists presented by Bayer

Nov. 23, 2017

Ardelyx discontinues development of RDX-7675

Nov. 22, 2017

Calliditas Therapeutics gives update on phase III study plans for Nefecon

Nov. 21, 2017

FDA extends review period for Tlando NDA

Nov. 20, 2017

Bayer discovers new vasopressin receptor antagonists

Nov. 17, 2017

Investigational mineralocorticoid receptor antagonist KBP-5074 evaluated in phase I trial

Nov. 17, 2017

Achillion reports preliminary data from phase II study of ACH-4471 in C3G

Nov. 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...